Updated Jul 16, 2026
Pignagnoli Agosti Marcello has filed 2 SEC Form 4 filings across 1 company in the last 90 days.
Marcello Pignagnoli Agosti is an executive at Takeda Pharmaceutical Company Limited, serving as the Head of Strategic and Portfolio Development. His role involves overseeing strategic initiatives and portfolio management within the company, contributing to its growth and innovation in the pharmaceutical sector.
| Role | Head, Strat. & Port. Dev. |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-06 | TAK | TAKEDA PHARMACEUTICAL CO LTD | A — Grant or award | 27.6K | $0.00 | |
| 2026-04-28 | TAK | TAKEDA PHARMACEUTICAL CO LTD | A — Grant or award | 27.7K | $0.00 |
Marcello Pignagnoli Agosti is an executive at Takeda Pharmaceutical Company Limited, serving as the Head of Strategic and Portfolio Development. His role involves overseeing strategic initiatives and portfolio management within the company, contributing to its growth and innovation in the pharmaceutical sector.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Pignagnoli Agosti Marcello profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.